Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleeding: Its Feasibility Compared with Transjugular Intrahepatic Portosystemic Shunt by Choi, Young Ho et al.
Korean J Radiol 4(2), June 2003 109
Balloon-Occluded Retrograde Transvenous
Obliteration for Gastric Variceal Bleeding:
Its Feasibility Compared with Transjugular
Intrahepatic Portosystemic Shunt
Objective: To assess the feasibility of balloon-occluded retrograde transve-
nous obliteration (BRTO) in active gastric variceal bleeding, and to compare the
findings with those of transjugular intrahepatic portosystemic shunt (TIPS).
Materials and Methods: Twenty-one patients with active gastric variceal
bleeding due to liver cirrhosis were referred for radiological intervention. In 15
patients, contrast-enhanced CT scans demonstrated gastrorenal shunt, and the
remaining six (Group 1) underwent TIPS. Seven of the 15 with gastrorenal shunt
(Group 2) were also treated with TIPS, and the other eight (Group 3) underwent
BRTO. All patients were followed up for 6 to 21 (mean, 14.4) months. For statisti-
cal inter-group comparison of immediate hemostasis, rebleeding and
encephalopathy, Fisher’s exact test was used. Changes in the Child-Pugh score
before and after each procedure in each group were statistically analyzed by
means of Wilcoxon’s signed rank test.
Results: One patient in Group 1 died of sepsis, acute respiratory distress syn-
drome, and persistent bleeding three days after TIPS, while the remaining 20 sur-
vived the procedure with immediate hemostasis. Hepatic encephalopathy devel-
oped in four patients (one in Group 1, three in Group 2, and none in Group 3);
one, in Group 2, died while in an hepatic coma 19 months after TIPS. Rebleeding
occurred in one patient, also in Group 2. Except for transient fever in two Group-3
patients, no procedure-related complication occurred. In terms of immediate
hemostasis, rebleeding and encephalopathy, there were no statistically signifi-
cant differences between the groups (p > 0.05). In Group 3, the Child-Pugh score
showed a significant decrease after the procedure (p = 0.02).
Conclusion: BRTO can effectively control active gastric variceal bleeding, and
because of immediate hemostasis, the absence of rebleeding, and improved liver
function, is a good alternative to TIPS in patients in whom such bleeding, accom-
panied by gastrorenal shunt, occurs.
he prevalence of gastric varices in patients with portal hypertension is ap-
proximately 30% (1 3), lower than that of esophageal varices. The fre-
quency with which gastric varices bleed is 3 30% (4 8), and because of
the greater and faster blood flow - and in spite of various treatment modalities - the
rupture of gastric varices results in a higher mortality rate (45 55%) than in cases in
which esophageal varices rupture (4, 8 10).
Shunt surgery, endoscopic injection sclerotherapy and transjugular intrahepatic por-
tosystemic shunt (TIPS) have been used for gastric varices. Shunt surgery, however, is
invasive, and patients with poor hepatic functional reserve are contraindicated for
surgery (11, 12). Endoscopic injection sclerotherapy is usually ineffective for varices
located in the gastric cardia and fundus: an easy endoscopic approach is not possible,
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Tand fast intra-variceal blood flow causes the rapid loss of
sclerosing agents (13, 14). TIPS was developed in order to
overcome the limitations of surgery and endoscopic injec-
tion sclerotherapy (15, 16), but has not always induced the
regression of gastric varices (17).
Shunt surgery and TIPS are aimed at relieving portal hy-
pertension by redirecting portal blood flow into systemic
circulation. Consequently, these treatments result in de-
creased portal hepatic blood flow, which may cause liver
failure and can aggravate hepatic encephalopathy (18
20).
Kanagawa et al. (14) recently introduced a less invasive
radiological procedure for the obliteration of gastric
varices. Involving a gastrorenal or gastrocaval shunt and
known as balloon-occluded retrograde transvenous obliter-
ation of gastric varices (BRTO), the procedure increases
portal blood flow in the liver, leading to improved liver
function. Satisfactory results for gastric varices accompa-
nied by or without hepatic encephalopathy have been re-
ported (3, 7, 21 25). Although BRTO was in most cases
performed as a prophylactic measure, one report claimed
that it was effective in urgent cases involving acute gastric
variceal bleeding (26). To the best of our knowledge, how-
ever, no published report has compared the use of BRTO
and TIPS in cases involving active gastric variceal bleeding.
The purpose of this prospective study was to assess the
feasibility of BRTO in such cases, comparing the outcomes
with those of TIPS.
MATERIALS AND METHODS
Patients
Between July 1999 and May 2001, 21 patients [M:F=
17:4; mean age, 57 (range, 42 80) years] were referred to
our hospital for radiological intervention because of active
gastric variceal bleeding due to liver cirrhosis. The cirrhosis
was caused by HBV in eleven patients, HCV in six, and
chronic alcohol ingestion in four. In seven patients, hepato-
cellular carcinoma was also present.
In order to determine an appropriate interventional pro-
cedure, all patients underwent CT scanning, and en-
doscopy was also performed in all patients except number
1, in whom it was impossible because of massive he-
matemesis. Gastric varices located in gastric cardia and the
gastric fundus were detected in all patients, and active
bleeding from varices was observed. At CT, a gastrorenal
shunt was demonstrated in 15 patients.
The six patients without gastrorenal shunt (Group 1) un-
derwent TIPS. One of the 15 with gastrorenal shunt, pa-
tient 21, had diffuse hepatocellular carcinoma of the liver
and underwent BRTO. The 14 remaining patients were
randomly assigned to one of two groups, ‘TIPS’ or ‘BRTO’.
Thus, among patients with gastrorenal shunt, seven under-
went TIPS (Group 2) and eight underwent BRTO (Group
3). The patients’ demographic data are summarized in
Table 1, which shows that three patients had a history of
hepatic encephalopathy prior to active gastric bleeding.
Differences between the three groups in terms of Child-
Pugh liver function score were not significant. In all cases,
written informed consent to the procedures was obtained
from patients or their families.
TIPS procedure
First, the patency of hepatic and portal veins was as-
sessed by CT scanning. By means of the transjugular ve-
nous approach, venography of the right and, if necessary,
middle hepatic vein was performed. To visualize portal
veins, CO2-wedged hepatic venography was routinely per-
formed. For TIPS tract creation, a Ring transjugular intra-
hepatic access set (Cook, Bloomington, Ind., U.S.A.) was
used; in twelve of the thirteen patients, a shunt tract was
created between the right hepatic and right portal vein,
and in the other, between the middle hepatic and left por-
tal vein because of bland thrombosis of the right portal
vein. After puncturing the portal veins, portal venography
was performed and the pressure gradient between the por-
tal vein and right atrium was measured. Before stent inser-
tion, the tract was dilated with a 10-mm balloon catheter
(Ultra-thin Diamond ; Boston Scientific, Watertown, Mass.,
U.S.A.). Self-expandable stents, Wallstent (Boston
Scientific) (n=8) or Niti-S (Taewoong, Seoul, Korea) (n=5),
were deployed in the shunt tract prior to further dilatation
with a 10-mm balloon catheter. Portal venography and
pressure measurement were repeated.
BRTO procedure (Fig. 1)
The right internal jugular vein was punctured in all pa-
tients. A 7-Fr occlusion balloon catheter with maximum 12
mm ballooning (Clinical Supply, Gifu, Japan) was inserted
into the left adrenal vein through the left renal vein. For
confirmation of feeding veins, draining veins, and gastric
varix collaterals, digital subtraction angiography was per-
formed, with the balloon inflated. If collateral gastric
variceal drainage veins were identified, they were em-
bolized with microcoils, glue, or gelatin sponge particles to
prevent leakage of the sclerosing agent into systemic circu-
lation.
The sclerosing agent used was a mixture of 5%
ethanolamine oleate (Keuk Dong Pharmaceuticals, Inchon,
Korea) and iodized oil (Lipiodol(r); Laboratoire Guerbet,
Riossy, France), mixed in a ratio of 3:1 6:1. The volume
of sclerosing agent prepared depended on the volume of
Choi et al.
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manual injection. Using an occlusion balloon catheter with
the balloon inflated, the agent was slowly infused into the
gastrorenal shunt in a retrograde fashion until the vascular
space in the gastric varices was completely opacified and
feeding veins from the portal or splenic veins began to be
visualized. The total of injected volume of sclerosing agent
ranged from 13 to 36 (mean, 25) mL; to facilitate its com-
plete infusion, the Sengstaken-Blakemore tube inserted for
hemostasis was deflated. The injected sclerosing agent re-
mained in the varix for three hours with the balloon inflat-
ed, and as much of it as possible was then aspirated under
fluoroscopy. To confirm the cessation of blood flow within
the shunt, venography was performed.
Follow-up
Patient 1 died three days after TIPS, but the remaining
twenty patients were followed up for 6 to 21 (mean, 14.4)
months. We reviewed their medical records and maintained
telephone contact with them. Immediate hemostasis, hepat-
ic encephalopathy, rebleeding and survival were moni-
tored, and changes in the amount of ascites and the Child-
Pugh score before and after the procedures determined.
Other than patient 10, those in whom TIPS was performed
underwent Doppler ultrasonography during follow-up, and
the patency of the TIPS tract and portal flow were thus as-
sessed. In patients who underwent BRTO, CT was per-
formed during the follow-up period, permitting evaluation
of the obliteration of gastric varices and the gastrorenal
shunt. Post-procedural endoscopic evaluation of gastric
varices was performed in three Group-1 patients, three in
Group 2, and six in Group 3. Immediately occurring proce-
dure-related complications were also investigated.
For statistical inter-group analysis in terms of immediate
hemostasis, rebleeding and encephalopathy, Fisher’s exact
test was used, and changes in the Child-Pugh score before
and after the procedure in each group were statistically an-
alyzed by means of Wilcoxon’s signed rank test.
RESULTS
The results of the procedures are summarized in Table 1.
Group 1
After TIPS, the portosystemic pressure gradient fell to
below 12 mmHg, and completion portography showed
that in all patients except number 4, whose pressure gradi-
ent was 19 mmHg, gastric varices had disappeared. Patient
1 died of sepsis, acute respiratory distress syndrome and
persistent bleeding three days after the procedure, but in
the remaining five patients, immediate hemostasis was
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xachieved. During the follow-up period, no rebleeding oc-
curred. Post-TIPS hepatic encephalopathy occurred in one
patient, number 3, who underwent liver transplantation
two months after TIPS. The post-TIPS Child-Pugh score
showed a decrease in three patients and an increase in the
other three. Follow-up duplex sonography indicated that
the patency of the TIPS tract was well maintained and
there was no disturbance of portal flow. Follow-up en-
doscopy, performed in patients 3, 4 and 6, indicated that
the varices had disappeared or become smaller.
Group 2
The post-TIPS portosystemic pressure gradient fell to be-
low 12 mmHg, except in patient 12, whose gastric varix
Choi et al.
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AB
Fig. 1. Balloon-occluded retrograde transvenous obliteration of gastric varix.
A. CT scan obtained before balloon-occluded retrograde transvenous obliteration shows dilated gastric varix (arrowheads) and gastrore-
nal shunt (arrow).
B. Narrow segment of the shunt tract (arrow) is demonstrated at angiography.
C. Gastric varix (small arrows), gastrorenal shunt (large arrow), and its multiple fine collaterals (arrowheads) are seen at angiography. In
the narrow segment, an inflated balloon catheter (long arrow) is visible.
D. With the balloon inflated (arrow), 2 2 2-mm gelatin sponge particles were injected into the gastrorenal shunt, from where they
flowed into collateral veins. Subsequent angiography shows that the fine collaterals have disappeared.
CDwas not opacified at post-TIPS portography despite an un-
satisfactory gradient decrease (17 mmHg). In patient 8, be-
cause of persistent filling of the gastric varix at completion
portography, post-TIPS coil embolization of the gastric
varix was performed. Two patients, numbers 7 and 9, un-
derwent post-TIPS balloon angioplasty for splenic vein
stenosis. Immediate hemostasis was achieved in all pa-
tients, and no immediate procedure-related complication
occurred.
During the follow-up period, rebleeding occurred in one
patient (number 13) five months after TIPS because of an
occluded TIPS tract. TIPS revision failed to reopen this
tract sufficiently, and a satisfactory reduction in the por-
tosystemic pressure gradient was thus not achieved. To
control the varix, BRTO was thus performed, and there
was no further rebleeding. In patients 9, 10 and 12, hepatic
encephalopathy developed; hepatic failure 18 months after
TIPS led to the death of patient 10. The post-TIPS Child-
Pugh score decreased in two patients, increased in three,
and showed no change in the other two. Follow-up en-
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EF
E. Three hours after the injection of ethanolamine oleate into the varix, as much as possible of the remaining sclerosing agent was aspi-
rated. Fluoroscopy shows that some, however, was retained.
F. Immediate follow-up angiography demonstrates obliteration of both the varix and gastrorenal shunt.
G. Follow-up CT scan obtained three months after balloon-occluded retrograde transvenous obliteration depicts contraction of the varix
(arrowheads) and gastrorenal shunt (arrow), with deposition of sclerosing agent.
H. One year later, there is no trace of either the varix or shunt.
GHdoscopy in patients 9 and 10 showed that the varices had
become smaller or disappeared entirely.
Group 3
Embolization of collateral channels was performed in
four patients. One patient, number 18, removed the occlu-
sion balloon catheter herself after thirty minutes, but the
injected sclerosing agent remained in situ without pul-
monary embolism.
Immediate hemostasis was achieved in all patients. Fever
developed in two, numbers 14 and 15, but subsided after
conservative therapy. Otherwise, no immediate procedure-
related complications occurred. The post-BRTO Child-
Pugh score decreased in seven patients and showed no
change in the other. During the follow-up period, neither
rebleeding nor hepatic encephalopathy were encountered.
Follow-up CT showed that in all patients, gastric varices
were filled with sclerosing agents or obliterated. Follow-up
endoscopy performed in six patients (numbers 14 17, 19,
and 21) revealed that varices had either disappeared or
were smaller, though in patient 16 a newly developed
esophageal varix was discovered two months after BRTO.
With respect to immediate hemostasis (p > 0.05), re-
bleeding (p > 0.05) and encephalopathy (p > 0.05), there
were no statistically significant differences between the
groups. A significantly decreased post-procedural Child-
Pugh score was found in Group 3 (p = 0.02), but not in
Groups 1 (p = 0.91) or 2 (p = 0.89).
DISCUSSION
TIPS has been considered the standard therapy for gas-
tric varices unresponsive to pharmacological and endo-
scopic treatment, but recent reports have claimed that for
their management, transvenous obliteration (BRTO) is less
invasive and more effective than shunt surgery or TIPS
(10 25). TIPS does not always induce their disappearance,
and according to one report (17), the improvement rate af-
ter TIPS is only 50%. BRTO, on the other hand, can in
most cases completely obliterate these varices. Chikamori
et al. (27) reported the complete obliteration of gastric
varices, demonstrated at CT, in all their 52 patients treated
with BRTO. Our study also demonstrated complete obliter-
ation in all our eight patients who underwent the proce-
dure, a finding confirmed at follow-up CT.
To date, BRTO has been applied electively, as a prophy-
lactic measure, in the treatment of gastric varices, but in
this study it was used for the emergent or urgent treatment
of active gastric variceal bleeding. Immediate hemostasis
was achieved and no rebleeding was noted during follow-
up, and BRTO was thus as effective as TIPS in the control
of bleeding.
The spontaneous portosystemic (splenorenal or gastrore-
nal) shunt reported to occur in 28% of patients with portal
hypertension (28) can increase the risk of chronic hepatic
encephalopathy (29). In such patients, TIPS can cause in-
tractable hepatic encephalopathy due to the increased
shunt volume (30). LaBerge reported an 18% incidence of
hepatic encephalopathy after TIPS (31), and in our study,
its incidence among Group 1 patients (gastric varix without
gastrorenal shunt and TIPS) was similar. Group 2 (gastric
varix with gastrorenal shunt and TIPS) showed a higher in-
cidence, however: hepatic encephalopathy occurred in
three of the seven patients. In BRTO, however, a sponta-
neous portosystemic shunt is occluded, and hepatic en-
cephalopathy is thus not an obstacle. Hirota et al. (3) rec-
ommended BRTO rather than TIPS for patients with gas-
tric varices in association with a gastrorenal shunt or hepat-
ic encephalopathy, and in our series of gastric variceal
bleeding, no case of hepatic encephalopathy arose through
the use of BRTO.
The augmentation of portal blood flow in BRTO (shunt
occlusion therapy) can improve liver function in cirrhotic
liver (23, 32), but TIPS (shunt creation therapy), on the
other hand, may decrease portal flow, leading to deteriora-
tion in liver function (33). In our study, the Child-Pugh
score showed a statistically significant improvement in pa-
tients who underwent BRTO, though in three TIPS patients
in Group 1 and three in Group 2, the Child-Pugh score
worsened.
The occlusion of a gastrorenal shunt, the main way of re-
ducing portal venous pressure, may - if there are no other
collateral vessels outside the esophageal wall or elsewhere
- aggravate existing esophageal varices or lead to the de-
velopment of new ones, and this is one of the most signifi-
cant complications of BRTO (21, 27). In our series, for ex-
ample, a new esophageal varix was detected at follow-up
endoscopy two months after BRTO in one patient. These
varices can, however, largely controlled by endoscopic in-
jection sclerotherapy or variceal ligation (21).
TIPS can give rise to various procedure-related complica-
tions such as hepatic arterial injury and hemoperitoneum
due to extrahepatic puncture, and stenosis or occlusion of a
TIPS tract is frequently observed during follow-up. In our
study, however, there were no notable TIPS-related com-
plications.
Since BRTO requires balloon occlusion to block the out-
flow of the gastric varix, as well as retrograde injection of
the sclerosing agent, the existence of a dilated suprarenal
vein for use as the usual draining vein should be confirmed
before the procedure. Also, since TIPS requires an appro-
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portal vein, the exact relation between these two vessels
should also be pre-procedurally determined. Thin-section
helical CT may play an important role in the evaluation of
a gastric varix, gastrorenal shunt, and the hepatic vascular
anatomy, and careful interpretation of the CT scans should
help lay the groundwork for the proper interventional pro-
cedure.
The occlusion of collateral veins connected to a gastrore-
nal shunt is essential for successful BRTO. Hirota et al. (3)
devised a five-point scale to classify the degree of progres-
sion of gastric varices and collateral veins, basing their sys-
tem on the results of adrenal venography performed dur-
ing balloon occlusion. Except for grade 5, in which the left
adrenal vein could not be occluded by the balloon catheter
because of a very large gastrorenal shunt with rapid blood
flow, the appropriate embolization of collateral veins lead
to successful BRTO. In our study, collateral veins were em-
bolized in four patients, and the embolic materials used
were glue, coils, and Gelfoam. When multiple fine collater-
als existed, we retrogradely injected 2 2 2-mm gelatin
sponge particles into the gastrorenal shunt tract while the
proximal adrenal vein was occluded with an occlusion bal-
loon catheter (Fig. 1).
Conner et al. (34) and Hoak et al. (35) reported that
ethanolamine oleate promptly binds with albumin in the
blood, thus becoming inactive, and decomposes to form
oleic acid and ethanolamine. If only a small amount is
used, it is therefore safe for local treatment. Its possible
side effects include, however, pulmonary embolism, renal
dysfunction, pleural effusion, pulmonary edema, hypersen-
sitivity reaction, pyrexia, and disseminated intravascular
coagulation syndrome, and it also causes hemolysis of the
blood vessels, leading to free hemoglobin, which may give
rise to renal tubular disturbance and renal insufficiency. In
BRTO, a relatively large amount of ethanolamine oleate is
used, and to prevent or minimize systemic complications it
is therefore important to prevent its abrupt systemic in-
flow. The various preventative measures which can be
used include allowing sufficient ballooning time for clot-
ting, the aspiration of any ethanolamine oleate remaining
in a gastrorenal shunt and gastric varix, and the emboliza-
tion of collateral veins connected to a gastrorenal shunt.
Some reports (3, 7, 14, 21 23) have described the intra-
venous injection of haptoglobin, which combines with free
hemoglobin, to prevent renal insufficiency associated with
hemolysis; in this study, we kept a balloon catheter inflated
for three hours and aspirated as much of the infused scle-
rosing agent as possible.
Because of the small number of patients in this study and
the different follow-up periods involved, there may be cer-
tain problems asscociated with statistical analysis. Even
though there was no statistical difference with respect to
encephalopathy between Group 1 and Group 3 (p = 0.38)
or between Group 2 and Group 3 (p = 0.08), we are left
with the impression that in a study involving more patients
there would be significant differences between groups, es-
pecially between Group 2 and Group 3, and that the re-
sults would be more exact. To overcome these limitations,
further studies involving a larger series and longer follow-
up period are needed.
In conclusion, BRTO can effectively control active gastric
variceal bleeding, and because of immediate hemostasis,
the absence of rebleeding, and improved liver function, is a
good alternative to TIPS in patients in whom such bleed-
ing, accompanied by gastrorenal shunt, occurs.
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